View in browser

Dr. Eskander, who advances oncology through innovative gynecology oncology research, will lead Moores CTO into a new era of discovery and patient care. In his role as CTO Director, Dr. Eskander will work closely with Moores Associate Director of Clinical Research, Dr. Rana McKay and Moores Physician-in-Chief, Dr. Ayad Hamdan, in directing the disease-team-based clinical research portfolios at Moores CTO. 

Great science is not enough to secure NIH grants—grantspersonship skills also must be mastered. In addition to the grant development and submission support available to Moores Members from the Moores Grant Development Team and Moores Pre-Award Research Administration, UC San Diego faculty and staff currently have access to a suite of NIH grant development resources, created by the Bouvier Grant Group, through a license provided by UC San Diego library. These virtual, self-paced resources are a US$6,000 value and address F, K, P, R, and U series grants; typical submission mistakes and best practices; and time management strategies, among other topics. Moreover, an “Ask the Grantwriting Expert” virtual office hour component enables the ability to ask questions about submissions in real time. Use the button below to peruse the Bouvier resources and register to use them—be sure to activate the campus VPN on your device. 

Moores Member Dr. Jyoti Mayadev and her colleagues have published new findings from their clinical trial Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): A randomised, double-blind, Phase III trial.

Tuesday, December 12, 2023 | 12:00 p.m.

Leichtag Biomedical Research Building Room 107

Wednesday, December 13, 2023 | 12:00 p.m.

Leichtag Biomedical Research Building Room 107

Monday, December 18, 2023 | 10:00 a.m. to 11:00 a.m.

Center for Novel Therapeutics, La Jolla Shore Conference Room (1st Floor)

Join Dr. Ricardo Zayas (San Diego State University) and Dr.  Yuan Chen (UC San Diego) to gain expert advice on oncology research. 

In 2024, the ALSF Crazy 8 Initiative will target childhood cancer predisposition and prevention. This is an opportunity for an investigator to form a team of experts to leverage this award of $3–5 million over 4 years to improve the well-being of children with cancer and their families.

Deadline for Letter of Intent: January 4, 2024 at 8:00 p.m. ET

With this Notice of Funding Opportunity (NOFO), the NCI invites applications for investigator-initiated studies addressing mechanisms by which incretin mimetics, specifically glucagon-like peptide (GLP)-1 or dual GLP-1/glucose dependent insulinotropic polypeptide (GIP)-1 receptor agonists, impact cancer risk. The agents are important because of not only their reported effects on thyroid, prostate, and other cancer risks, but also the generally more favorable efficacy and side effect profile, compared to other classes of incretin mimetics.

Deadline: January 5, 2024

The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a highly related group of cancers. 

Deadline: January 25, 2024; May 25, 2024; September 25, 2024

The purpose of this NOFO is to promote the discovery, development, and validation of real-world digital endpoints derived from data generated by existing remote or wearable devices. These endpoints will be used for monitoring not  only the experience of pain, but also its progression, response to interventions, and impact on quality of life.

Deadline: January 30, 2023

Cancer Discovery

Trey Ideker, PhD (Structural and Functional Genomics)

Nature Nanotechnology

Liangfang Zhang, PhD (Solid Tumor Therapeutics)

Nature Genetics

Ludmil B. Alexandrov, PhD (Structural and Functional Genomics)

PI: Shumei Kato, MD

NCT: NCT05097599

PI: Joel Baumgartner, MD

NCT: NCT02463877

PI: Shumei Kato, MD

NCT: NCT05691491

Join COE for the last CHEC workgroup meeting of the year, which will include (1) presentations from ACS CAN and ZERO Prostate Cancer and (2) an introduction to PFAS and cancer risks on behalf of the San Diego Fire Rescue Department. Capitalize on this opportunity to network and connect with community partners. Register Now

Tune in to the latest episode of The Science Of . . . podcast, brought to you by the Teen Center of the Jackie Robinson Family YMCA, Moores COE, and Cloudcast Media. In this episode, the teens explore the science of clinical trials and careers, with Moores Clinical Research Coordinator, Natalia Ortuno. Get to know Natalia and her journey to a career in STEM, her advice for those considering similar pathways, and her knowledge of coordinating clinical trials. Listen Here

On Thursday, December 7, 2023, 27 individuals participated in a Prostate Health 101 Community Workshop, which included vendors and presenters at the Jackie Robinson Family YMCA. Presentations were given by Kris Bennett of ZERO Prostate Cancer, prostate cancer patient and survivors Russell Steppe and Ken Marlborough, and Moores Member Dr. Brent Rose, who addressed prostate cancer incidence and mortality disparities in communities of color—particularly the Black and African American community. Community members enjoyed dinner alongside resources from HHSA’s Office of Equitable Communities and Immunization Branch, JIREH Providers, ZERO Prostate Cancer, and Moores. Follow-up outreach events already are being planned—stay tuned for announcements. 

On Wednesday, December 6, 2023, Moores COE greeted and gave cancer prevention information and snacks to 106 visitors while hosting a vendor table at the Community Health and Resource Fair at the Jackie Robinson Family YMCA. COE also will attend the first fair of 2024 on February 7, 2024. Save this date and pass it along to members of the community.

Department of Research Administration

3855 Health Sciences Drive, La Jolla, CA 92037

moorescancercenter.ucsd.edu

Unsubscribe | Privacy Policy | Submit Feedback